Member Info for EmeraldCarrots

Tick up - 1.52p/1.54p

Sp is in fact up. The bid at close on Friday was 1.5p. It's now 1.52p. Skewed by Fridays uncrfossing trade by the market makers (mm's). The sp is a steal at this price IMHO.

All IMHO.

Increase!!!!!!!!!!!!!!!!!!!!!!!!!!!!! See chart. Company in far better position now. I have taken up Fridays retail offer.

All IMHO.

The management of any neonatal hospital on planet Earth would also struggle to sell a 2-litre bottle of cold water to a person dying of thirst IMHO. To be able to test that a baby won't have a bad reaction to an antibiotic that might render the it completely deaf is a salespersons dream come true.

All IMHO.

All important. Neonatal hospitals all over the world, strangeley enough, want the Genedrive MT-RNR1. Not rocket science as to why.................... Sales will snowball.

All IMHO.

Https://www.manchester.ac.uk/about/news/genetic-test-for-deafness-in-newborns-to-be-trialled-across-the-uk/

I can see finally things are starting to pick up. It's incredible the UK's NHS, NICE, etc.. have dragged their feet for so long. Still doing it in fact. But we are making steady progress which is increasing. From the Half year report "· Distributors contracted in key international geographies, with site installations in Italy and Saudi Arabia and additional sites expected near-term". Near term......... expect news soon then. Some of these orders could be huge don't forget.

The FDA application for this machine needs to be done asap. This is key to Genedrive'a future. Once it has FDA clearance (license to sell in the USA) the value of Genedrive Plc will quadrouple. Jist hope the management realise this!

Should easily be able to convince any neonatal hospital in the World this machine is vital to prevent antibiotic induced hearing loss and prevent possible legal action. Sales of said machine should ROCKET in the coming months. I suspect we will get bought out as soon as we get the FDA approval enabling sales in the USA.

All IMHO.

Be it monitoring HER2, or finding and monitoring biomarkers during any cancer drug trial. Then the long wait Angle Plc share holders have had WILL BE OVER. I've almost convinced myself Mr Newland runs out of the building and hides in his car if the phone rings and it's about a commercial deal. LOL!

All IMHO.

Rocket79.

""AstraZeneca deal coming imo."

==============

Beauty of that is if we get one deal we will get multiple deals, and not just with Astrazeneca. £ millions.

Hmm.....!

Hmm.....

Approach yet. The list of positives is now huge. I mean just getting the FDA approval for selling the Genedrive® MT-RNR1 in the USA will be massive news. With the right backing the Genedrive® MT-RNR1 could be a "must have" for all the neonatal hospitals in the USA. The FDA have already confirmed there IS NO OTHER MACHINE THAT DOES THE SAME available in the whole USA! £100 million plus profit in time? I find this situation completely ridiculous. The Company is undervalued by a totally ridiculous margin. The sp should be fivefold what is actually is.

All IMHO.

Excellent point. Next Tuesday is start of April.

FDA applications for both machines.

Genedrive® CYP2C19.

"510(k) route identified for regulatory submission for US market entry, with initial pre-submission engagement with Food and Drug Administration (FDA) held and feedback positive and with regulatory approach confirmed as appropriate".

========

Genedrive® MT-RNR1

"Breakthrough Device Designation received from the FDA. Progressing as planned, with first engagement with FDA under programme initiated".

One or both these applications are likely to me made in the next few months by the looks.

FDA approval = can be sold anywhere in the USA......................

Genedrive® MT-RNR1 has already been confirmed as being UNIQUE to the USA market....... ***NO COMPETITION AT ALL!!!" “"Breakthrough Device Designation received from the FDA”

All IMHO.

Up 1.3%.

Up 28.83%

Up 28%.

Yesterday mms playing".

Really? Shows up 28% now on my live feed.